Good morning :)
Godavari Drugs Ltd

Godavari Drugs Ltd

GODAVARI Share Price

BSE
80.103.66% (+2.83)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹62 cr, stock is ranked 3,517

Stock is 4.21x as volatile as Nifty

GODAVARI Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹62 cr, stock is ranked 3,517

Stock is 4.21x as volatile as Nifty

GODAVARI Performance & Key Metrics

GODAVARI Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
16.901.44
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.595.770.58%

GODAVARI Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

GODAVARI Company Profile

Godavari Drugs is engaged in the contract manufacturing, loan license manufacturing, manufacturing and supply of active pharmaceutical ingredients (APIs), drug intermediaries and fine chemicals

GODAVARI Similar Stocks (Peers)

Compare with peers Compare with peers 

GODAVARI Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
39.50
39.50
1Y Return
11.49%
11.49%
Buy Reco %
94.29
94.29
PE Ratio
76.46
76.46
1Y Return
41.15%
41.15%
Buy Reco %
81.48
81.48
PE Ratio
19.20
19.20
1Y Return
14.36%
14.36%
Buy Reco %
50.00
50.00
PE Ratio
32.64
32.64
1Y Return
16.12%
16.12%
Buy Reco %
72.22
72.22
PE Ratio
20.24
20.24
1Y Return
9.62%
9.62%
Buy Reco %
54.84
54.84
Compare with Peers

GODAVARI Forecast

GODAVARI Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

GODAVARI

GODAVARI

Income

Balance Sheet

Cash Flow

GODAVARI Income Statement

GODAVARI Income Statement

Loading...

Quartersep 2023dec 2023mar 2024jun 2024sep 2024dec 2024mar 2025jun 2025sep 2025dec 2025
Total Revenue39.5543.1638.7532.9726.1029.6525.6123.8227.2822.45
Operating & Other expensessubtract36.4839.6534.2028.9823.1826.9722.3920.9124.6519.71
Depreciation/Amortizationsubtract0.490.500.530.550.580.640.670.600.600.61
Interest & Other Itemssubtract1.301.271.231.441.081.111.111.000.911.11
Taxes & Other Itemssubtract0.420.520.130.380.160.150.550.260.120.26
EPS1.141.623.532.171.451.021.191.381.331.01

GODAVARI Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2025FY 2025

Annual report

PDF
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
 

GODAVARI Stock Peers

GODAVARI Past Performance & Peer Comparison

GODAVARI Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Godavari Drugs Ltd14.271.44
Sun Pharmaceutical Industries Ltd39.505.960.89%
Torrent Pharmaceuticals Ltd76.4619.250.74%
Dr Reddy's Laboratories Ltd19.203.200.61%

GODAVARI Stock Price Comparison

Compare GODAVARI with any stock or ETF
Compare GODAVARI with any stock or ETF
GODAVARI
Loading...

GODAVARI Holdings

GODAVARI Shareholdings

GODAVARI Promoter Holdings Trend

GODAVARI Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

GODAVARI Institutional Holdings Trend

GODAVARI Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

GODAVARI Shareholding Pattern

GODAVARI Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding52.61%0.00%0.50%0.00%46.89%

Mar 2025

Jun 2025

Sep 2025

Dec 2025

GODAVARI Shareholding History

GODAVARI Shareholding History

SepDec '24MarJunSepDec '250.00%0.00%0.00%0.00%0.00%0.00%

GODAVARI Insider Trades & Bulk Stock Deals

GODAVARI Insider Trades & Bulk Stock Deals

Loading...

smallcases containing GODAVARI stock

smallcases containing GODAVARI stock

Looks like this stock is not in any smallcase yet.

GODAVARI Events

GODAVARI Events

GODAVARI Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

GODAVARI has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

GODAVARI Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

GODAVARI has not given any dividends in last 5 years

GODAVARI Dividends

GODAVARI Dividends

Hmm, looks like data is unavailable here. Please come back after some time

GODAVARI Stock News & Opinions

GODAVARI Stock News & Opinions

Earnings
Godavari Drugs standalone net profit declines 1.30% in the December 2025 quarter

Net profit of Godavari Drugs declined 1.30% to Rs 0.76 crore in the quarter ended December 2025 as against Rs 0.77 crore during the previous quarter ended December 2024. Sales declined 24.94% to Rs 22.18 crore in the quarter ended December 2025 as against Rs 29.55 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales22.1829.55 -25 OPM %11.148.70 - PBDT1.381.56 -12 PBT0.770.92 -16 NP0.760.77 -1 Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Corporate
Godavari Drugs to discuss results

Godavari Drugs will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Corporate
Godavari Drugs to convene EGM

Godavari Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 12 February 2026.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Godavari Drugs announces board meeting date

Godavari Drugs will hold a meeting of the Board of Directors of the Company on 15 January 2026.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Godavari Drugs standalone net profit declines 8.26% in the September 2025 quarter

Net profit of Godavari Drugs declined 8.26% to Rs 1.00 crore in the quarter ended September 2025 as against Rs 1.09 crore during the previous quarter ended September 2024. Sales rose 2.15% to Rs 26.65 crore in the quarter ended September 2025 as against Rs 26.09 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales26.6526.09 2 OPM %7.4711.12 - PBDT1.721.83 -6 PBT1.121.25 -10 NP1.001.09 -8 Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Godavari Drugs to hold board meeting

Godavari Drugs will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Godavari Drugs reschedules AGM date

Godavari Drugs has revised the Annual General Meeting of the company which was scheduled to be held on 28 August 2025. The meeting will now be held on 27 August 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
Godavari Drugs to hold AGM

Godavari Drugs announced that the Annual General Meeting(AGM) of the company will be held on 27 September 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live
Earnings
Godavari Drugs standalone net profit declines 36.20% in the June 2025 quarter

Net profit of Godavari Drugs declined 36.20% to Rs 1.04 crore in the quarter ended June 2025 as against Rs 1.63 crore during the previous quarter ended June 2024. Sales declined 26.08% to Rs 23.81 crore in the quarter ended June 2025 as against Rs 32.21 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales23.8132.21 -26 OPM %12.1410.03 - PBDT1.902.56 -26 PBT1.302.01 -35 NP1.041.63 -36 Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
Godavari Drugs schedules AGM

Godavari Drugs announced that the Annual General Meeting(AGM) of the company will be held on 13 August 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Godavari Drugs Ltd (GODAVARI) today?

    The share price of GODAVARI as on 6th March 2026 is ₹80.10. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Godavari Drugs Ltd (GODAVARI) share?

    The past returns of Godavari Drugs Ltd (GODAVARI) share are
    • Past 1 week: -1.05%
    • Past 1 month: -11.28%
    • Past 3 months: 9.62%
    • Past 6 months: -4.18%
    • Past 1 year: -18.48%
    • Past 3 years: 2.38%
    • Past 5 years: 95.84%

  3. What are the peers or stocks similar to Godavari Drugs Ltd (GODAVARI)?
  4. What is the market cap of Godavari Drugs Ltd (GODAVARI) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Godavari Drugs Ltd (GODAVARI) is ₹62.52 Cr as of 6th March 2026.

  5. What is the 52 week high and low of Godavari Drugs Ltd (GODAVARI) share?

    The 52-week high of Godavari Drugs Ltd (GODAVARI) is ₹115 and the 52-week low is ₹69.70.

  6. What is the PE and PB ratio of Godavari Drugs Ltd (GODAVARI) stock?

    The P/E (price-to-earnings) ratio of Godavari Drugs Ltd (GODAVARI) is 14.27. The P/B (price-to-book) ratio is 1.44.

  7. Which sector does Godavari Drugs Ltd (GODAVARI) belong to?

    Godavari Drugs Ltd (GODAVARI) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Godavari Drugs Ltd (GODAVARI) shares?

    You can directly buy Godavari Drugs Ltd (GODAVARI) shares on Tickertape. Simply sign up, connect your demat account and place your order.